Other
FX Effect on Cash
Vertex Pharmaceuticals FX Effect on Cash decreased by 652.1% to -$40.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 232.1%, from $30.50M to -$40.30M. Over 3 years (FY 2021 to FY 2025), FX Effect on Cash shows an upward trend with a 92.1% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant values indicate high exposure to international markets and currency volatility, requiring effective hedging strategies.
Detailed definition
The impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balances held in...
Peer comparison
Standard for multinational corporations; peers with similar geographic footprints will show similar sensitivity.
Metric ID:
fx_effectHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | -$8.50M | -$4.90M | -$5.90M | -$25.90M | -$38.20M | $12.00M | $10.00M | -$22.50M | $27.40M | -$15.60M | -$2.50M | $22.80M | -$47.30M | $30.50M | $57.20M | $0.00 | $7.30M | -$40.30M |
| QoQ Change | — | -312.5% | +42.4% | -20.4% | -339.0% | -47.5% | +131.4% | -16.7% | -325.0% | +221.8% | -156.9% | +84.0% | >999% | -307.5% | +164.5% | +87.5% | -100.0% | — | -652.1% |
| YoY Change | — | — | — | — | -747.5% | -349.4% | +303.4% | +138.6% | +41.1% | — | -230.0% | -125.0% | +201.3% | -272.6% | +295.5% | >999% | -100.0% | +115.4% | -232.1% |
Range-$47.30M – $57.20M
CAGR+67.1%
Avg YoY Growth+101.9%
Median YoY Growth-29.5%
FX Effect on Cash at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's fx effect on cash?
- Vertex Pharmaceuticals (VRTX) reported fx effect on cash of -$40.30M in Q1 2026.
- How has Vertex Pharmaceuticals's fx effect on cash changed year-over-year?
- Vertex Pharmaceuticals's fx effect on cash decreased by 232.1% year-over-year, from $30.50M to -$40.30M.
- What is the long-term trend for Vertex Pharmaceuticals's fx effect on cash?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's fx effect on cash has grown at a 92.1% compound annual growth rate (CAGR), from -$13.40M to $95.00M.
- What does fx effect on cash mean?
- The change in cash value caused by foreign currency exchange rate fluctuations.